Estimating severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence from residual clinical blood samples, January-March 2021

• Main Authors: Daniel S. Graciaa (Author), Hans P. Verkerke (Author), Jeannette Guarner (Author), Ana Maria Moldoveanu (Author), Narayanaiah Cheedarla (Author), Connie M. Arthur (Author), Cheryl L. Maier (Author), Andrew Neish (Author), Sara C. Auld (Author), Angie Campbell (Author), Neel R. Gandhi (Author), John D. Roback (Author), N. Sarita Shah (Author)
• Format: Book
• Published: Cambridge University Press, 2022-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

We describe severe acute respiratory coronavirus virus 2 (SARS-CoV-2) IgG seroprevalence and antigenemia among patients at a medical center in January-March 2021 using residual clinical blood samples. The overall seroprevalences were 17% by infection and 16% by vaccination. Spent or residual samples...